Abstract

Bone morphogenetic proteins (BMPs) play an important role in nephrogenesis. The biologic effect and mechanism of action of these proteins in the adult kidney has not yet been studied. We investigated the effect of BMP2, a member of these growth and differentiation factors, on mitogenic signal transduction pathways induced by platelet-derived growth factor (PDGF) in glomerular mesangial cells. PDGF is a growth and survival factor for these cells in vitro and in vivo. Incubation of mesangial cells with increasing concentrations of BMP2 inhibited PDGF-induced DNA synthesis in a dose-dependent manner with maximum inhibition at 250 ng/ml. Immune complex tyrosine kinase assay of PDGF receptor beta immunoprecipitates from lysates of mesangial cells treated with PDGF showed no inhibitory effect of BMP2 on PDGF receptor tyrosine phosphorylation. This indicates that the inhibition of DNA synthesis is likely due to postreceptor events. However, BMP2 significantly inhibited PDGF-stimulated mitogen-activated protein kinase (MAPK) activity that phosphorylates the Elk-1 transcription factor, a component of the ternary complex factor. Using a fusion protein-based reporter assay, we also show that BMP2 blocks PDGF-induced Elk-1-mediated transcription. Furthermore, we demonstrate that BMP2 inhibits PDGF-induced transcription of c-fos gene, a natural target of Elk-1 that normally forms a ternary complex that activates the serum response element of the c-fos gene. These data provide the first evidence that in mesangial cells, BMP2 signaling cross-talks with MAPK-based transcriptional events to inhibit PDGF-induced DNA synthesis. One target for this inhibition is the early response gene c-fos.

Highlights

  • Bone morphogenetic proteins (BMPs) play an important role in nephrogenesis

  • We studied the effect of different concentrations of BMP2 on platelet-derived growth factor (PDGF)-induced DNA synthesis

  • Unlike TGF-␤, BMP2 does not increase fibronectin mRNA expression in mesangial cells. This finding may have broader implication to the potential use of BMP2 as antimitotic agent in proliferative and fibrotic disorders. These studies demonstrate that BMP2 inhibits PDGF-induced DNA synthesis in mesangial cells by blocking PDGFstimulated mitogen-activated protein kinase (MAPK) activity that leads to inhibition of Elk-1-dependent transcriptional events and c-fos gene expression

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 274, No 16, Issue of April 16, pp. 10897–10902, 1999 Printed in U.S.A. Goutam Ghosh Choundhury‡§, Yong-soo Kim, Matthias Simon¶, John Wozneyʈ, Stephen Harris, Nandini Ghosh-Choundhury**‡‡, and Hanna E. It has been reported recently that activation of epidermal growth factor receptor, a tyrosine kinase, leads to phosphorylation of Smad in serine residues in a MAPK-dependent manner. This phosphorylation inhibits localization of Smad in the nucleus inhibiting its transcriptional function [14]. Fibroblast growth factor-induced genes essential for tooth development can be blocked by BMP2 [17] These data indicate that there is cross-talk between BMP receptor serine threonine kinase and its components and the receptor tyrosine kinase cascades. In support of this mechanism, we show that BMP2 inhibits PDGF-mediated c-fos gene transcription in mesangial cells

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.